Hyperion Defi (HYPD) Interest Coverage Ratio (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Interest Coverage Ratio of 38.66 for Q1 2026, up 841.77% year-over-year from 4.11 in Q1 2025, and up 222.74% quarter-over-quarter from 31.5 in Q4 2025.
Hyperion Defi (HYPD) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Interest Coverage Ratio for 10 consecutive years, with 38.66 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 841.77% year-over-year to 38.66; the TTM figure through Mar 2026 stood at 15.61 (up 8.14% YoY), while the FY2025 annual figure was 0.94, up 95.22% from the prior year.
- Interest Coverage Ratio climbed to 38.66 in Q1 2026 per HYPD's latest filing, from 31.5 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 38.66 in Q1 2026 and bottomed at 49.49 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 11.82 across 5 years, with a median of 9.6 in 2023.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 238.46% — and 2026, when it soared 841.77%.
- Hyperion Defi's Interest Coverage Ratio stood at 18.76 in 2022, then tumbled by 159.57% to 11.18 in 2023, then tumbled by 238.46% to 37.84 in 2024, then increased by 16.75% to 31.5 in 2025, then soared by 222.74% to 38.66 in 2026.
- Business Quant data shows HYPD's Interest Coverage Ratio at 38.66 in Q1 2026, 31.5 in Q4 2025, and 19.85 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 132.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.65 |
| Mar 31, 2026 | 38.66 |
| Dec 31, 2025 | -31.50 |
| Sep 30, 2025 | 19.85 |
| Jun 30, 2025 | -15.81 |
| Mar 31, 2025 | -5.21 |
| Dec 31, 2024 | -37.84 |
| Sep 30, 2024 | -4.49 |
| Jun 30, 2024 | -6.44 |
| Mar 31, 2024 | -5.15 |
| Dec 31, 2023 | -11.18 |
| Sep 30, 2023 | -9.60 |
| Jun 30, 2023 | -2.33 |
| Mar 31, 2023 | -12.02 |
| Dec 31, 2022 | 18.76 |
| Sep 30, 2022 | -40.82 |
| Jun 30, 2022 | -46.41 |
| Mar 31, 2022 | -49.49 |
| Dec 31, 2021 | 16.47 |
| Sep 30, 2021 | -49.70 |